rdf:type |
|
lifeskim:mentions |
umls-concept:C0002716,
umls-concept:C0002932,
umls-concept:C0022180,
umls-concept:C0035647,
umls-concept:C0205145,
umls-concept:C0291573,
umls-concept:C0442805,
umls-concept:C1280500,
umls-concept:C1287349,
umls-concept:C1554184,
umls-concept:C1709634,
umls-concept:C1879547
|
pubmed:issue |
1
|
pubmed:dateCreated |
2011-6-24
|
pubmed:abstractText |
?-Amyloid protein (A?) accumulation, caspase activation, apoptosis, and hypoxia-induced neurotoxicity have been suggested to be involved in Alzheimer disease neuropathogenesis. A? is produced from amyloid precursor protein through proteolytic processing by the aspartyl protease ?-site amyloid precursor protein-cleaving enzyme (BACE) and ?-secretase. Inhaled anesthetics have long been considered to protect against neurotoxicity. However, recent studies have suggested that the inhaled anesthetic isoflurane may promote neurotoxicity by inducing caspase activation and apoptosis, and by increasing levels of BACE and A?. We therefore sought to determine whether isoflurane can induce concentration-dependent dual effects on hypoxia-induced caspase-3 activation and increases in BACE levels: protection versus promotion.
|
pubmed:grant |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Amyloid Precursor Protein Secretases,
http://linkedlifedata.com/resource/pubmed/chemical/Amyloid beta-Peptides,
http://linkedlifedata.com/resource/pubmed/chemical/Amyloid beta-Protein Precursor,
http://linkedlifedata.com/resource/pubmed/chemical/Anesthetics, Inhalation,
http://linkedlifedata.com/resource/pubmed/chemical/Aspartic Acid Endopeptidases,
http://linkedlifedata.com/resource/pubmed/chemical/BACE1 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Caspase 3,
http://linkedlifedata.com/resource/pubmed/chemical/Isoflurane,
http://linkedlifedata.com/resource/pubmed/chemical/Neuroprotective Agents
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
1526-7598
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:volume |
113
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
145-52
|
pubmed:dateRevised |
2011-11-9
|
pubmed:meshHeading |
pubmed-meshheading:21519046-Amyloid Precursor Protein Secretases,
pubmed-meshheading:21519046-Amyloid beta-Peptides,
pubmed-meshheading:21519046-Amyloid beta-Protein Precursor,
pubmed-meshheading:21519046-Anesthetics, Inhalation,
pubmed-meshheading:21519046-Aspartic Acid Endopeptidases,
pubmed-meshheading:21519046-Caspase 3,
pubmed-meshheading:21519046-Cell Hypoxia,
pubmed-meshheading:21519046-Cell Line, Tumor,
pubmed-meshheading:21519046-Dose-Response Relationship, Drug,
pubmed-meshheading:21519046-Enzyme Activation,
pubmed-meshheading:21519046-Humans,
pubmed-meshheading:21519046-Isoflurane,
pubmed-meshheading:21519046-Neuroprotective Agents
|
pubmed:year |
2011
|
pubmed:articleTitle |
The potential dual effects of anesthetic isoflurane on hypoxia-induced caspase-3 activation and increases in ?-site amyloid precursor protein-cleaving enzyme levels.
|
pubmed:affiliation |
Geriatric Anesthesia Research Unit, Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital and Harvard Medical School, 149 13th St., Room 4310, Charlestown, MA 02129-2060, USA.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't,
Research Support, N.I.H., Extramural
|